| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/13/1998 | CA2280048A1 Il-8 receptor antagonists |
| 08/13/1998 | CA2279946A1 Mediation of cytokines by melanin |
| 08/13/1998 | CA2279575A1 Human sdf-5 protein and compositions |
| 08/13/1998 | CA2279233A1 Arginine silicate complex and use thereof |
| 08/13/1998 | CA2277544A1 Identification of inhibitors of protein tyrosine kinase 2 |
| 08/12/1998 | EP0857175A1 Novel human cysteine protease |
| 08/12/1998 | EP0857061A1 Solubilisation methods |
| 08/12/1998 | CN1190437A 骨刺激因子 Bone-stimulating factor |
| 08/12/1998 | CN1190020A Chinese herbal medicine powder for pharmacotherpaeutic shoulder shield |
| 08/12/1998 | CN1190019A Ointment for trauma and fracture and its preparation |
| 08/11/1998 | US5792772 Enatiomerically pure hydroxylated xanthine compounds |
| 08/11/1998 | US5792762 Dihydrobenzofluorene compounds, intermediates, compositions and methods |
| 08/06/1998 | WO1998033916A2 Secreted proteins and polynucleotides encoding them |
| 08/06/1998 | WO1998033811A1 Peptides comprising a t-cell epitope specific to collagen ii |
| 08/06/1998 | WO1998033788A1 Matrix metalloproteinase inhibitors |
| 08/06/1998 | WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives |
| 08/06/1998 | WO1998033508A1 Calcareous material |
| 08/06/1998 | WO1998024763A3 Immunotherapeutic imides/amides as pde iv and tnf inhibitors |
| 08/06/1998 | WO1998021332A3 Secreted proteins and polynucleotides encoding them |
| 08/06/1998 | CA2279594A1 Calcareous material |
| 08/06/1998 | CA2278638A1 Peptides comprising a t-cell epitope specific to collagen ii |
| 08/06/1998 | CA2278595A1 Secreted proteins and polynucleotides encoding them |
| 08/05/1998 | EP0856007A1 Cyclopeptide derivatives |
| 08/05/1998 | EP0855917A1 Stable pharmaceutical forms of administration containing parathormone |
| 08/05/1998 | EP0855884A1 Bone grafting matrix |
| 08/05/1998 | EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/05/1998 | EP0642518B1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism |
| 08/05/1998 | CN1189832A Diazepino-indoles as phosphodiesterase IV inhibitors |
| 08/05/1998 | CN1189374A Chinese medicine for treating gout |
| 08/04/1998 | US5789400 Cardiovascular disorders |
| 08/04/1998 | US5789395 Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| 08/04/1998 | US5788987 Time-specific controlled release dosage formulation |
| 08/04/1998 | US5788984 Gestodene-containing agent for transdermal administration |
| 08/04/1998 | CA2101275C Methods for the treatment of osteoporosis |
| 07/30/1998 | WO1998032766A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS |
| 07/30/1998 | WO1998032748A1 Sulfamide-metalloprotease inhibitors |
| 07/30/1998 | WO1998032734A1 SUBSTITUTED β-THIOCARBOXYLIC ACIDS |
| 07/30/1998 | WO1998032733A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 07/30/1998 | WO1998032730A1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 07/30/1998 | WO1998032457A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 07/30/1998 | WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | WO1998032450A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells |
| 07/30/1998 | WO1998032425A1 Pharmaceutical formulations with delayed drug release |
| 07/30/1998 | WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors |
| 07/30/1998 | WO1998024780A3 Substituted pyrimidinone and pyridinone compounds and their use |
| 07/30/1998 | WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity |
| 07/30/1998 | DE19802350A1 Sulfamid-Metalloprotease-Inhibitoren Sulfamide metalloprotease inhibitors |
| 07/30/1998 | CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 07/30/1998 | CA2278737A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 07/30/1998 | CA2278539A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells |
| 07/30/1998 | CA2278152A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/29/1998 | EP0854884A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor |
| 07/29/1998 | EP0854870A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 07/29/1998 | EP0580650B1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof |
| 07/29/1998 | CN1189151A 维生素d类似物 Vitamin d analogues |
| 07/29/1998 | CN1189105A Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagenosis |
| 07/29/1998 | CN1039327C Novel thio-substituted nitrogen-containing heterocyclic phosphonate compounds, pharmaceutical compositions and pharmacy application |
| 07/28/1998 | US5786360 Antiallergens, central nervous system stimulants, diuretics, antihistamines, cardiotonic agents; water solubility |
| 07/28/1998 | US5786352 Cyclic compounds, their production and use |
| 07/28/1998 | US5786327 Polypeptides for bone disorders |
| 07/23/1998 | WO1998032022A1 Growth factor-dependent diseases |
| 07/23/1998 | WO1998031802A2 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | WO1998031798A1 Human extracellular matrix-1 |
| 07/23/1998 | WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | WO1998031702A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | WO1998031664A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 07/23/1998 | WO1998031359A1 Integrin antagonists |
| 07/23/1998 | WO1998031227A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | DE19701607A1 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung Anitkörper that bind to the nidogen-binding domain of laminin, their preparation and use |
| 07/23/1998 | CA2403927A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2278477A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | CA2278307A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | CA2278153A1 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | CA2278055A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/22/1998 | EP0854145A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0854140A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 07/22/1998 | EP0853667A2 Bone stimulating factor |
| 07/22/1998 | EP0643767B1 Osteogenic peptides |
| 07/22/1998 | CN1188482A Colchicine derivatives, use thereof and formulations containing them |
| 07/21/1998 | US5783558 Treatment of bone disorders; calcium regulation |
| 07/16/1998 | WO1998030706A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | WO1998030693A2 Tumor necrosis factor receptor 5 |
| 07/16/1998 | WO1998030590A2 Analogs of parathyroid hormone |
| 07/16/1998 | WO1998030589A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030586A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | WO1998030566A1 Cyclic sulfone derivatives |
| 07/16/1998 | WO1998030551A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFα SECRETION |
| 07/16/1998 | WO1998030542A1 Vitronectin receptor antagonists |
| 07/16/1998 | WO1998030541A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | WO1998030537A1 Nitric oxide synthase inhibitors |
| 07/16/1998 | WO1998030191A1 Material intended to remineralise organomineral tissues |
| 07/16/1998 | WO1998024463A3 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 07/16/1998 | WO1998019697A3 Novel pharmaceutical compositions |
| 07/16/1998 | CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | CA2277582A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | CA2277105A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | CA2276738A1 Vitronectin receptor antagonists |
| 07/16/1998 | CA2276088A1 Secreted proteins and polynucleotides encoding them |